Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Medical Technology Company Secures Neurostimulation Device Approval In Brazil

Nexalin Technology's Gen-2 Neurostimulation Device Receives Approval in Brazil.
On June 17, 2024, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), a company known for its innovative neurostimulation products, announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency (ANVISA). ANVISA is a regulatory body under the Brazilian government responsible for the approval of new drugs and medical devices. This landmark approval marks a significant milestone for Nexalin Technology as it expands its reach into one of the largest markets in the world. $NEXALIN TECHNOLOGY INC C/WTS ( TO PUR COM )(NXLIW.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
881 Views
Comment
Sign in to post a comment
    176Followers
    0Following
    399Visitors
    Follow